# Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]

> **NCT02104063** · — · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 78 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Penis

## Interventions

- **PROCEDURE:** MRI-PET

## Key facts

- **NCT ID:** NCT02104063
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-22
- **Primary completion:** 2016-07-22
- **Final completion:** 2016-07-22
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02104063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02104063, "Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT02104063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*